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Abstract
Background: Most low- and middle-income countries (LMIC) rely significantly on private health expenditure in the
form of out-of-pocket payments (OOP) and voluntary health insurance (VHI). This paper assesses VHI expenditure
trends in LMIC and explores possible explanations. This illuminates challenges deriving from changes in VHI
expenditure as countries aim to progress equitably towards universal health coverage (UHC).
Methods: Health expenditure data was retrieved from the WHO Global Health Expenditure Database to calculate
VHI, OOP and general government health (GGHE) expenditure as a share of total health expenditure (THE) for the
period of 1995–2012. A literature analysis offered potential reasons for trends in countries and regions.
Results: In 2012, VHI as a percentage of THE (abbreviated as VHI%) was below 1 % in 49 out of 138 LMIC.
Twenty-seven countries had no or more than five years of data missing. VHI% ranged from 1 to 5 % in 39
LMIC and was above 5 % in 23 LMIC. There is an upwards average trend in VHI% across all regions. However,
increases in VHI% cannot be consistently linked with OOP falling or being redirected into private prepayment.
There are various countries which exhibit rising VHI alongside a rise in OOP and fall in GGHE, which is a less
desirable path in order to equitably progress towards UHC.
Discussion and Conclusion: Reasons for the VHI expenditure trends across LMIC include: external influences;
government policies on the role of VHI and its regulation; and willingness and ability of the population to
enrol in VHI schemes. Many countries have paid insufficient attention to the potentially risky role of VHI for
equitable progress towards UHC. Expanding VHI markets bear the risk of increasing fragmentation and
inequities. To avoid this, health financing strategies need to be clear regarding the role given to VHI on the
path towards UHC.
Keywords: Private health insurance, Voluntary health insurance, Universal health coverage, Low- and middle-
income countries, Health expenditure
* Correspondence: mathaueri@who.int
1Department of Health Services Research and Policy, London School of
Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH,
UK
2Department of Health Systems Governance and Financing, World Health
Organization, Avenue Appia, Geneva, Switzerland
© 2016 Pettigrew and Mathauer. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Pettigrew and Mathauer International Journal for Equity in Health  (2016) 15:67 
DOI 10.1186/s12939-016-0353-5
Background
Countries are increasingly determined to move towards
universal health coverage (UHC). This involves creating
financing mechanisms to ensure “that all people can use
the health services they need, of sufficient quality to be ef-
fective, while also ensuring that the use of these services
does not expose the user to financial hardship” [1]. This
progress towards UHC should be equitable in that lower
income and other vulnerable or disadvantaged population
groups should equitably benefit from progress rather than
being left out until later [2]. Yet many low- and middle-
income countries (LMIC) are still far from reaching UHC,
as they rely significantly on private health expenditure
(PvtHE) as a share of total health expenditure (THE).
Most of PvtHE is made up of regressive out-of-pocket
payments (OOP). Another part of PvtHE is private health
insurance, now more frequently referred to as voluntary
health insurance (VHI), which is also usually a more re-
gressive form of prepayment than tax revenue or social se-
curity funds (referred to here as public health insurance)
and offers a more limited form of risk sharing. Overall,
PvtHE is thus a more inequitable form of health financing,
through which it is more difficult to progress towards
UHC in an equitable way.
This paper focuses on VHI in LMIC. Increases in VHI
expenditure as a mechanism to finance health systems
have implications on countries’ efforts to move towards
UHC. We do not argue that there is a threshold of VHI
share that is harmful for UHC progress, but global evi-
dence suggests that VHI is not a suitable mechanism to
move towards UHC in an equitable way given its regres-
sive nature and other reasons outlined further below [1].
It is therefore important to be aware of trends in VHI ex-
penditure and to respond to potential challenges deriving
from changes in VHI expenditure and the role VHI plays.
For countries of the Organisation for Economic Co-
operation and Development (OECD) and the European
Union various reviews of VHI expenditure trends, often
previously referred to private health insurance (PHI), as
well as country specific analyses are available [3–7]. Sekhri
and Savedoff (2005) provide a global overview and de-
scriptive analysis of the share of PHI from THE in 2001.
They indicate that in 2001 PHI expenditure was above
5 % of THE in 39 countries worldwide, 25 (64 %) of these
being LMIC, pointing out how widespread PHI had be-
come across the globe [8]. Drechsler and Jütting (2005)
provided an analysis of PHI as a share of THE from 1997
to 2001 based on National Health Accounts (NHA) [8, 9]
which included LMIC, and gave an update for the period
1998-2002. They observed a rising, although so far overall
small PHI shares of THE in LMIC [10, 11]. To note, glo-
bally, there is no relationship (R2 = 0.01) between GDP
per capita and VHI% [12], which was also earlier observed
by Drechsler and Jütting [10].
However there are no more recent publications pre-
senting and exploring overall trends in VHI expenditure
globally in LMIC with NHA data after 2002. The signifi-
cance and role of VHI may have changed during this
period as many LMIC have begun to place more attention
on their health financing system. The purpose of this paper
is therefore to provide a comprehensive overview of VHI
expenditure trends in LMIC and to explore potential rea-
sons for these trends throughout the whole period of avail-
able NHA data since 1995 and with an additional 10 years
of data since the previous studies. This NHA data is made
available through the World Health Organization’s (WHO)
Global Health Expenditure Database (GHED) [13]. As such,
this paper also serves as a data repository on VHI expend-
iture as a basis for further country analysis and future
research.
Voluntary health insurance (VHI) schemes are based
voluntary prepayment of premiums with the mode of
participation being upon the discretion of an individual
or a firm or group. Benefits are agreed between the
beneficiary and insurer. This is in contrast to compul-
sory schemes where membership and payment of contri-
butions are made compulsory by the government (by
law) for the population as a whole or large sections of
the community. VHI appears in many forms: there are
large commercial schemes as well as smaller non-profit
ones. They include employer-based insurance contracts,
and community-based health insurance (CBHI) [14].
There are different categorizations of the role of VHI
in relation to public health insurance [5, 6]. The OECD
categorization of VHI functions distinguishes between the
following: Primary; complementary; supplementary; or du-
plicative [5] which are further explained in Table 1. In
practice, several roles for VHI for different population
groups may co-exist in a country. It is often difficult to
distinguish primary from supplementary VHI coverage
when there is only a vaguely defined package of services,
in particular if they are of poor quality, or actually not
available in practice.
The extent of advantages and disadvantages of VHI de-
pends on its specific type. Each of the four types outlined
above has potential positive (foremost reducing OOP ex-
penditure) and negative implications in progressing towards
UHC, through specific effects on access, equity and effi-
ciency from a health system perspective. When prepayment
levels through compulsory sources are minimal, VHI as a
form of prepayment and limited pooling could be prefera-
ble to OOP expenditure, as it may expand financial protec-
tion and access to additional services [1]. VHI has also been
argued to potentially bring more money into the health sys-
tem and to cross-subsidise at provider level as well as to en-
hance uptake of new technologies [5, 6, 9, 15]. However,
VHI can suffer from a number of market failures due to ad-
verse/risk selection, leading to a spiral of increasing
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premiums, further enhancing adverse selection, thus poten-
tially making VHI unaffordable and creating market instabil-
ity. VHI can significantly contribute to fragmentation and
unbalanced risk pools in public health insurance with a lar-
ger proportion of sicker patients. It builds up barriers to re-
distribute funding in favour of the poor or sick and thus
increases inequity in access if not well regulated. VHI can
also lead to increased use of unnecessary health care due to
moral hazard and supplier-induced demand, this may be a
particular issue for supplementary and complementary VHI.
Most importantly due to group interests and associated
resistance, it may be politically more difficult to introduce
or expand compulsory prepayments to finance coverage
extension for less affluent population groups when a VHI
market is already in place. This is can be seen in particular
where primary VHI coverage exists, even if it only covers
a small percentage of the population or contributes a
modest amount to the share of THE.
The next section describes the methodology for this
study. The results presents trends in VHI expenditure in
LMIC and identifies factors that may explain these. A dis-
cussion follows which brings together three emergent
themes of factors from a global perspective which may in-
fluence the development and role given to VHI. Finally
conclusions, policy lessons and implications in relation to
VHI and equitable progress towards UHC are offered.
Methods
This study is based on data from the WHO’s GHED
downloaded in December 2014. This provided data for
the years 1995–2012. Looking at the whole period for
which data is available helps to identify broader trends
and adds an additional 10 years of data to previous pub-
lications. The GHED covers all member states of the
World Health Organization, currently 194, and provides
a set of health expenditure data [13]. Data is added and
updated on a yearly basis by the WHO Health Accounts
team. Each country makes data available in a standardized
format by following the Health Accounts methodology,
considered as the international standard [14, 16]. The
Health Accounts methodology outlines basic accounting
criteria and guidance on timeliness, data completeness,
consistency and accuracy as well as data validation and tri-
angulation. This guidance aims to increase the reliability of
both public as well as private expenditure data collection.
However of particular concern is the data quality of
VHI expenditure data. The OECD’s Systems of Health
Accounts and WHO’s Guide to Producing Health Ac-
counts note that collecting data on VHI expenditure is
one of the most challenging out of all the health expend-
iture types. As the NHA guidebook states: “Incomplete
sources and estimation methods of private expenditure
on health are among the major limitations for
Table 1 Classification of VHI roles
VHI role Country examples
Primary
Principal: Represents the only available access to health insurance. In the United States of America, VHI has been the principal
source of coverage before 2014 [78].
Substitutive: Substitutes for cover which would otherwise be available
from the public health insurance system, but the individual has voluntarily
opted out of this or is not entitled to it. In the case of opting out, people
do not pay public health insurance contributions.
In Germany and Chile, opt out options from the public health insurance
system exist in order to be covered by VHI [3, 47]. Such substitutive VHI
often includes additional services and is thus also supplementary in nature.
Complementary
Complements coverage of publicly insured services or services within
principal/substitute health insurance, by covering all or part of the
residual costs (e.g. co-payments).
France’s complementary VHI primarily serves to reimburse copayments
required in the public health insurance system [79].
Community based health insurance schemes in Sub-Saharan Africa usually
cover user fees, although they may also represent a form of principal
voluntary health insurance.
Supplementary
Covers additional health services not covered by the public scheme;
depending on the country this may include for example elective care,
long-term care, dental care, pharmaceuticals, rehabilitation, alternative or
complementary medicine, superior hotel and amenity hospital services.
In Germany supplementary VHI exists for additional services (e.g. dental
care, private hospital room). Similarly supplementary VHI is found in the
Russian Federation, Latvia and Hungary [80].
Duplicative
Covers health services already covered under public health insurance, but
with access to other, additional providers or levels of service, e.g. private
health facilities. However unlike substitutive insurance it does not exempt
enrollees from contributing to public health insurance.
In the United Kingdom duplicative VHI exists as an additional alternative
to the public system.
Similarly in Nicaragua, wealthy people may purchase VHI that provides
access to the private sector and coverage of additional services that are
not included in the mandatory public scheme. Yet, they continue paying
public health insurance contributions [81].
Source for classification of VHI roles [5]
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international comparison” [16]. One specific challenge is
that health insurance may be part of other types of in-
surance (e.g. life insurance) or health insurance may
cover benefits beyond healthcare (e.g. income benefits)
which may be hard to disaggregate. Moreover, a fast
turnover of VHI organisations and limited or immature
market regulation can result in poor quality VHI data
being provided. These factors alongside others around
the timing of data collection and movement of funds be-
tween the insurer, policy holder and healthcare provider,
as well as the existence of reserve and surplus funds and
administrative costs, create potential limitations to the
accuracy of data [14, 16].
It also should be noted that the underlying terminology
and definitions for the NHA data currently available in
GHED is based on the System of Health Accounts 1.0 [17]
which uses the term private health insurance (PHI). How-
ever, the newer System of Health Accounts (SHA) 2011
edition has modified the classification and terminology in
order to be more precise and employs the term voluntary
health insurance [14]. In line with the SHA 2011 termin-
ology, this paper uses the term voluntary health insurance
to refer to private health insurance, although data is based
on the previous definitions.
The GHED includes estimates on GGHE (general gov-
ernment health expenditure) and PvtHE (private health
expenditure) as percentages of THE (total health expend-
iture) and as expenditure in national currency units. It
also provides OOP and VHI expenditure as a percentage
of PvtHE. Importantly the VHI data available does not
identify what role VHI is playing as outlined in Table 1.
Only further country context information and literature
analysis allows exploration of which VHI role prevails.
VHI expenditure as a share of THE was calculated
based on the share of PvtHE in THE multiplied by the
share of VHI expenditure in PvtHE. VHI expenditure as
a percentage of THE is abbreviated as “VHI%” as are
“OOP%” and “GGHE%” when respectively referring to
OOP and GGHE as a percentage of THE.
To explore VHI expenditure trends countries were
grouped by the WHO Regions as follows; African Region
(AFRO) Region of the Americas (AMRO), Eastern Medi-
terranean Region (EMRO), European Region (EURO),
South East Asian Region (SEARO) and Western Pacific Re-
gion (WPRO). Whilst there are differences between coun-
tries, this grouping is useful in that LMICs in these regions
show, on the whole, geographical and socio-economic simi-
larities. The 2012 World Bank classification of country in-
come levels was used to categorize countries into low,
lower-middle, upper-middle and high income. Countries
which moved into the high income classification between
2010 and 2012 were still included in the LMIC country
trend analysis. Otherwise their exclusion could have missed
relevant information on VHI trends as during the majority
of the period in question (1995–2012) they were considered
as LMIC.
Countries with no data or more than five years of data
missing on VHI expenditure during 1995–2012 were ex-
cluded from the calculation of the VHI% average by
WHO region. For country trend analysis within each re-
gional section below countries having had a VHI% ≥ 1 %
at least once during the last 5 years of the observation
period (i.e. 2008–2012) were included.
Grouped by WHO Regions the following individual
country data analyses are presented:
1. VHI% trends between 1995–2012
2. Summary tables in the Addendum (Additional file 2)
with:
a. the direction in change (rise or fall) of VHI, OOP
and GGHE as a share of THE (VHI%, OOP%,
GGHE%) between 1995 and 2012
b. OOP% of THE in 2012, grouped into 3 categories
(below 20 %, between 20–40 % and above 40 %)
Changes in per capita expenditure in purchasing power
parity dollars in VHI, OOP and GGHE were also analysed.
As was THE as a percentage of GDP. These have not been
presented in this paper but have helped informed the results
and analysis. In addition to assessing VHI expenditure
trends, potential reasons for the trends in VHI expenditure
were explored and interpreted based on analysis of the lit-
erature. A literature search of English publications was
undertaken in PubMed and Web of Knowledge starting
from 1990 to June 2015. Grey literature was searched for in
Google, for which the first 7 pages (70 results) were
screened for relevant material. Titles identified through the
search process were reviewed, and if found to be relevant
the abstract or executive summary was read. If this sug-
gested that the publication could provide a reason for the
trend in VHI expenditure the full publication was assessed.
Additional papers were identified through the reference list
of literature identified, as well as through the authors’ know-
ledge of relevant publications. Potential explanations for
trends in VHI expenditure were recorded and then analysed
to identify emerging themes. Health sector and health finan-
cing strategy documents available on the IHP+ Platform
were screened for whether they mentioned or defined the
role of VHI [18].
Results
Number of countries with VHI% data
The GHED provided information on 193 countries,
when data was downloaded. Out of these 55 countries
were classified as high-income countries (HIC) and 138
as LMIC in 2012. Figure 1 provides a summary of VHI data
availability by country income group. Twenty-seven LMIC
(20 %) had no data or more than five years of missing VHI
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expenditure data; these were excluded from further analysis
(listed in Additional file 1). This left 111 LMIC with avail-
able data. Seven HIC countries (Antigua and Barbuda,
Chile, Latvia, Lithuania, the Russian Federation, Uruguay
and Saints Kitts and Nevis) were included in the regional
analysis and in the literature search as they had been LMIC
for the majority of the 1995–2012 period (Fig. 2). From this
total of 118 countries, 20 countries reported zero VHI%
throughout the period, and 30 countries reported a VHI%
of below 1 % in 2012. Countries with a VHI% of below 1 %
in 2012 were excluded from the individual country trend
analysis and literature search, unless the VHI% had been
above 1 % at some point during the period of 2008–2012,
which was the case for five AFRO countries and one
WPRO country. In total, 74 countries met the final inclu-
sion criteria for individual country trend analysis.
VHI% trends by country income classification and by
WHO region
A total of 46 countries had VHI% > 5 % in 2012, of these
23 were LMIC and three countries had recently become
HIC (Fig. 1). Worldwide, 56 countries had VHI% be-
tween 1 % and 5 %, 39 of these were LMIC and three
had recently become HIC.
Figure 2 provides an overview of VHI% in LMIC in the
six WHO regions in 2012. AFRO, AMRO and EURO have
the greatest number of countries with missing data.
WPRO is the region with highest proportion of countries
Fig. 1 Overview of VHI in 2012 by country income classification
Fig. 2 Overview of VHI% in 2012 in LMIC + 7 recent HIC by WHO Region
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reporting zero expenditure on VHI. AMRO has the high-
est proportion of countries with VHI% > 5 % compared to
other regions. EURO, SEARO and WPRO have no coun-
tries with VHI% > 10 %.
Figure 3 shows the VHI% averages of LMIC by WHO
region during 1995–2012. With the exception of EMRO
countries, since 1995 the average VHI% in all regions
has increased slightly. The highest average VHI% is
found in AMRO.
Country VHI% trends in LMIC by WHO region
African Region (AFRO)
Out of the 46 AFRO LMIC, VHI expenditure data is re-
corded for 39 countries. The regional average VHI% for
Fig. 3 Average VHI% trends in LMIC + 7 recent HIC by WHO Region
Fig. 4 AFRO Individual country trends of VHI%, 1995–2012, VHI% >3 % in 2012
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AFRO appears fairly stable between 3.2 %–4.2 % with a
slight upward increase (see Fig. 3). Fifteen countries
recorded a VHI% of less than 1 % over the past five
years in 2012, and five countries reported zero VHI%
throughout 1995–2012. There is thus some consider-
able variance across AFRO countries, as revealed in
Figs. 4 and 5, which present individual country trends
of VHI% for 24 countries with a VHI% above 1 % be-
tween 2008-2012. The data has been split into two
graphs to enable reading with Figure 4 showing coun-
tries with VHI% <3 % in 2012 and Figure 5 those >3
% in 2012.
South Africa, Namibia and Botswana have a notably
much higher VHI% in comparison to other countries in
the region, with a significant increase in Botswana after
2002. Overall, though, only six countries have a VHI%
above 5 % in 2012. On looking more closely Senegal,
Benin and Rwanda respectively saw relatively sharp rises
in VHI% during the period in question.
For each country it was assessed whether there was an
overall rise or fall in OOP% and VHI% set against a rise
or fall in GGHE% (see Additional file 2). It shows that
the GGHE% increases in 20 out of 24 countries. In six of
these countries, both OOP% and VHI% go down, while in
the other 13 countries, VHI% increases, whilst OOP% de-
creases. Ghana is the only country with rising GGHE as
well as an OOP% increase, while VHI% declines. However,
in four countries (Tanzania, Mauritius, Namibia and
Kenya) GGHE% decreases, and notably the VHI% in-
creases in the latter two of these countries with OOP%
also going up. This scenario with a fall in GGHE%, rise in
VHI% and rise in OOP% is undesirable with respect to
equitably moving towards UHC.
Community based health insurance (CBHI) usually
covers user fees and thus primarily serves as complemen-
tary insurance, but also may provide additional services in
a supplementary role. As such, it has increasingly been
perceived as a possible avenue through which to improve
healthcare coverage in LMIC in Sub-Saharan Africa. The
uptake in the number of CBHI schemes [19] might be one
reason for high percentage increases in per capita VHI
spending massively outstripping the associated relative
percentage increase in THE per capita expenditure be-
tween 1995 and 2012, seen in Benin, Burkina Faso and
Senegal. Rwanda also showed a substantial rise in VHI%
and VHI expenditure per capita, which can be explained
by the government's decision in 2005 to nationally roll out
the CBHI schemes (Mutuelles de Sante) [20, 21]. These
have been counted as VHI even though enrolment has
been mandatory in practice and therefore their classifica-
tion will change under the new system of health accounts.
Despite heavy promotion by some development partners
and some ministries, rates of CBHI enrolment remain lim-
ited in most of the AFRO area [22]. Therefore ultimately,
increases in VHI expenditure via CBHI are also limited.
Thus, assumingly, some other part of the VHI expenditure
Fig. 5 AFRO Individual country trends of VHI%, 1995–2012, VHI%≤ 3 % in 2012
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increase may be explained by commercial VHI, also in a
complementary and supplementary role targeted at
wealthier segments of the population, although this re-
mains affordable to very few.
The much higher levels of VHI% preceding 1995 in
South Africa and Namibia were due to the long exist-
ence of VHI that served the more affluent populations
as primary (principal) coverage [11]. A similar develop-
ment occurred in Botswana, where a rising middle class
could afford VHI [23]. Notably, VHI% is much higher
than the percentage of the population covered by VHI.
The South African legacy of the apartheid period left a
very inequitable and fragmented health financing system.
VHI (called “medical aid schemes”) had been set up and
tailored to the needs of wealthy white urban populations
[24]. However, increasing unaffordability of VHI due to
high premiums led to a decline in VHI population cover-
age [25, 26]. There was also a fall in the number of VHI
funds [27]. Following the African National Congress
coming into power in 1994 there has been progress to
address these inequities, reflected in the falling OOP%
and rising GGHE% [28], which marginally reduced
VHI% in the post-apartheid period. Yet, the introduction
of market-oriented policies in 1996, which intended to
stimulate the economy were a barrier to quick growth in
public spending [29, 30]. It should also be noted that al-
though Zimbabwe has been omitted in this study due to
missing data, it also had a substantial percentage of THE
spent on VHI previously recorded (18 % in 2001), as re-
ported by Drechlser and Jütting [11].
In summary, in AFRO, there is no consistent trend re-
garding the VHI expenditure changes: On the one hand,
some Southern African countries (South Africa,
Namibia, Swaziland) with primary (principal) VHI,
which had historically relatively higher levels, show de-
creasing VHI%, largely due to increased GGHE.
Botswana and Senegal show exceptionally large increases
of more than 30 and 5 percentage points respectively in
VHI%. On the other hand, for countries with VHI%
below 8 %, there are both upward and downward devel-
opments within the range of 2 % percentage points for
most countries. In countries with an overall downward
trend, increasing VHI expenditure per capita due to a
growing increasing middle class demanding better (sup-
plementary and complementary) VHI coverage as well
as the promotion of CBHI schemes may thus be offset
by increased government commitment for higher
GGHE, which we argue is a more desirable direction on
the path to UHC [31].
American Region (AMRO)
Out of a total of 30 LMIC in AMRO, 26 have VHI
data. Figures 6 and 7 present the individual country
trends in VHI% from 1995–2012 for the 24 AMRO
countries with VHI% above 1 % in any year between
2008 and 2012. Included are also Chile, Uruguay,
Fig. 6 AMRO Individual country trends of VHI%, 1995–2012, VHI% > 5 % in 2012
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Antigua and Barbuda, and Saint Kitts and Nevis,
which recently became HIC. Together with AFRO,
AMRO has a much wider variation in VHI% com-
pared to other regions. It also has the greatest pro-
portion of countries with VHI% >5 %, and so AMRO
has had the highest average VHI% throughout the
18 year period (see Fig. 3). Although none of the
AMRO countries maintain as high a VHI% as South
Africa and Namibia, five AMRO countries maintained
a VHI% of >10 % during all of the 18 year period,
and only in the Dominican Republic did the VHI% of
15 % in 1995 decline and reach between 8–10 % from
2004 onwards. Likewise, Argentina shows a declining
trend since 2000. There are also several countries in
AMRO with relatively sharp variations in VHI ex-
penditure data. In the absence of plausible reasons to
explain such steep variations, questions around the
data itself arise, in particular in Uruguay where there
is a significant dip and then return to the previous
trend in the early 2000s. The data has been split into
two graphs to enable reading with Figure 6 showing
countries with VHI% <5 % in 2012 and Figure 7 those
>5 % in 2012.
In seven out of 24 countries included in the analysis,
GGHE% decreased, and in most of these, both VHI% and
OOP% increased, which is a less desirable health expend-
iture development in moving towards UHC equitably. On
the other hand, in 17 countries, GGHE% increased, with
just under half of these also showing an increase in VHI%,
while OOP% decreased (see Additional file 2).
For the 18 countries with a VHI% below 10 % in 2012,
the overall trend has been for the VHI% to rise, at least
during the first half of the period studied. In Suriname,
VHI exists in several roles: public health insurance is
primarily for civil servants, with voluntary membership
for others and the private formal sector is primarily cov-
ered via employer based health insurance or other VHI
[32]. This covered about 17 % of the population in 2002
[33] and may have contributed to the rises noted in
VHI%. In Colombia, the health sector underwent reform
in 1993 guided by international financial institutions that
contributed to a slight growth of VHI [34]. In the Do-
minican Republic it was reported that deficiencies in the
public tax financed system led to the initial growth of
the VHI sector, but in 2001 new laws created a social se-
curity system with public health insurance that led to
greater GGHE and caused VHI% in turn to fall gradually
over the 2000s [35]. In Mexico, the opt-out option from
the public health insurance scheme for private sector
formal employees and option to take primary (substitu-
tive) VHI instead since 1995 only led to a minor rise in
VHI%. This limited growth has been attributed to the
lack of regulation to support the private sector's growth
in a secure financial and fiscal environment [36]. High
VHI premiums constitute an important financial barrier
for the majority of the Mexican population. Moreover,
Fig. 7 AMRO Individual country trends of VHI%, 1995–2012, VHI%≤ 5 % in 2012
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the national public health insurance programs have been
reported to provide a relatively comprehensive package
[37].
In the group of countries with VHI% >10 % in 1995,
various of these, e.g. Chile, Argentina, Uruguay and
Brazil, have been influenced by market focused reforms
which were encouraged by multilateral lending agencies
prior to 1995 [38]. Income growth among the wealthier
population was also a reason for a rise in the VHI%. In
Brazil, for example, 25 % of the population have VHI
coverage, largely in its supplementary role [39, 40]. Like-
wise, in Chile, where opting out of public health insur-
ance was previously allowed, 25 % of the population
chose primary (substitutive) VHI coverage by 1997,
resulting in a significant rise in VHI%. Of note the VHI
schemes also manage the 7 % public health insurance
contribution, so only the contribution above the 7 % is
VHI in nature and includes supplementary coverage,
even though the current GHED data does not disaggre-
gate this and reports all as VHI.
Despite coalitions of health professionals, academics,
unions and local communities coming together to resist
reforms [38, 41] and with limited regulatory frameworks
in place described as a “legal vacuum” [36], the VHI mar-
ket grew substantially in the 1980s–90s. Health Mainten-
ance Organisations (HMO), often from overseas, emerged,
targeting the rising incomes and desires of the wealthier
middle-classes [42]. Yet, rising VHI premiums resulted in
reduced enrolment rates as found in Argentina [43] and in
fact contributed to a decline in VHI%. Importantly, in-
creased investment in GGHE to provide coverage to poor
and vulnerable groups in Uruguay, Brazil and Chile
coupled with firmer regulation [44, 45] have contributed
to a decline in VHI% in recent years. For example in Chile,
the introduction of AUGE (Acceso Universal con Garan-
tias Explicitas - Universal Access with Explicit Guarantees)
made public health insurance more appealing, which re-
sulted in VHI membership substantially falling and
remaining stable over more recent years [46, 47].
In summary, many Latin American countries reached
high VHI% levels, largely due to private sector policies in
the past as well as due to increasing demands of the popu-
lation. As a number of countries were strongly committed
to expanding GGHE and undertaking equity focused re-
form in efforts to move towards UHC since the mid-
2000s, VHI% has gone down in many settings, especially
in those countries which had VHI% levels above 10 % in
the 1990s.
Eastern Mediterranean Region (EMRO)
The average VHI% is around 3–4 % in the 15 EMRO coun-
tries (Fig. 3) that provided VHI expenditure data. There
were six countries with a VHI > 1 % in 2012. As Fig. 8 pre-
sents, three of these countries (Lebanon, Morocco, Tunisia)
had a VHI% above 5 % for the majority of the period in
question, and Jordan’s VHI% rose above 5 % in 2008.
Morocco has had a VHI% which is noticeably the highest
for all lower-middle income countries included in this
study. However Morocco and Tunisia show downward
trends in VHI%, whereas a strong upward trend is noted
for Jordan and Lebanon in the latter 2000s. Iran’s and
Egypt’s supplementary/complementary VHI markets are
still relatively small at less than 2.5 % of THE.
In four out of six countries (Jordan, Morocco, Lebanon,
Tunisia) GGHE% increases. In the remaining two countries
(Egypt and Iran), GGHE% decreases with slightly increas-
ing VHI%. OOP% decreases in Iran however it increases in
Fig. 8 EMRO Individual country trends of VHI%, 1995–2012
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Egypt, this being a less desirable trend with respect to
equitably moving towards UHC (see Additional file 2).
In Jordan limited public health insurance and eco-
nomic policies that promoted trade liberalization and
privatization have been offered as explanatory factors for
Jordan's steady rise in VHI% [48], where the VHI sector
comprises of private insurance companies, self-insured
firms, and third party administrators principally for the
upper-middle professional classes [49]. In addition co-
ordination between the Ministry of Industry and Trade,
which is responsible for VHI regulation, and the Minis-
try of Health has been reported to be limited [50]. In
Lebanon the VHI sector boomed post 1992 due to gaps
in public health insurance after the end of a 17 year
civil that had left the public sector with very limited
capacity and with a fragmented health system and
health financing structure [51, 52]. Despite improve-
ments in the government health sector, private sector
provision has still remained dominant and patients
faced high user charges. This may explain why VHI%
increased substantially in the mid-2000s, coupled with
a lack of effective control mechanisms, which led to
rising premiums.
The decrease in VHI% in Morocco can be explained
by an increase in GGHE% due to the expansion of com-
pulsory public health insurance from the mid-2000s on-
wards, although the speed of decline may be slower than
had been expected [53], also given the continued opting-
out option for employers to provide VHI to their em-
ployees [54]. A similar explanation may be valid for
Tunisia, where VHI play a supplementary but also pri-
mary (substitutive) role [55]. The lower VHI% rate found
in Egypt can be explained by a lack of regulation condu-
cive for the VHI sector to develop. This may explain
why OOPs in the private sector did not turn into supple-
mentary VHI [56].
In summary, the different trends found in this region
can be related to diverse reasons, namely: limited growth
in VHI% related to non-conducive conditions for the VHI
market to expand (Egypt), or improvements in public
provision and public health insurance (Tunisia, Morocco).
Vice versa larger growth in VHI% was also due to gaps in
public health insurance (Jordan, Lebanon).
European Region (EURO)
The availability of VHI expenditure data was very limited
for the 23 EURO LMIC countries, with only 12 countries
reporting VHI expenditure with less than five years of data
missing. Out of these, six countries had aVHI% > 1 % in any
year between 2008 and 2012 (Georgia, Hungary, Russian
Federation, Uzbekistan, Latvia and Turkey). Based on the
available data, EURO LMIC show the overall lowest average
VHI%, only since 2011 is the average VHI% slightly lower
in SEARO LMICs (see Fig. 3). It should be noted that the
Russian Federation and Latvia (and Lithuania which did
not have a VHI% >1 % between 2008 and 2012, so not in-
cluded in the trend analysis) became HIC in 2012. All
countries included with a VHI% > 1 % (see Fig. 9 for the
detailed country analysis) have seen an overall rise in
VHI% since 1995, but other than Hungary and Georgia,
the VHI% decreases from the early 2000s onwards. Ex-
cept for Georgia, VHI% remained below 5 % in all
countries.
In Hungary, Russian Federation and Latvia, the GGHE%
decreases, with both OOP% and VHI% increasing, which
we argue is not a desirable way of equitably moving to-
wards UHC. In contrast, in Georgia, Uzbekistan and
Fig. 9 EURO Individual country trends of VHI%, 1995–2012
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Turkey, GGHE% and VHI% increases, while OOP% goes
down (see Additional file 2). Some OOP expenditure is
likely to have been turned into VHI, and as total private
health expenditure is going down, the trend of these three
countries is going in a more desirable direction towards
UHC. However in terms of equity it may be preferable for
a greater part of OOP% to be redirected into GGHE% ra-
ther than to VHI%.
More than half of the EURO countries assessed here
have a hybrid financing system of payroll taxes and gov-
ernment budget transfers. With the exception of
Georgia, the other remaining countries have a national
health service in place. The legacy of the Soviet health
system model, with its strong focus on central govern-
ment funding and the absence of a private sector, would
explain why the majority of ex-Soviet countries have
very low VHI% (below 1 % or reported as 0 %). In the
post-Soviet transition lack of trust in private institutions
and affordability issues further contributed to this [11]. In
the Russian Federation, Latvia and Hungary, which have a
mandatory health insurance system that is also financed
through budget revenues, VHI plays largely a complemen-
tary and/or supplementary role [7, 57, 58]. This is also the
case in Uzbekistan with a state-run health system [6]. Of
note the cost of VHI policies is not regulated and these are
relatively high due to small risk pools and limited number
of sales, which makes them predominately accessible only
to higher income groups [59].
In Turkey, despite its growth, supplementary VHI
plays a minor role so far. It covers solely one percent of
the population, in particular higher income households
that seek supplementary coverage. A major reason for
the decline in VHI% in 2004 is linked to the Health
Transformation Program starting 2003 with increased
GGHE. This resulted in a decline of the share of the
population covered by VHI [60].
In Georgia in 1995, the government introduced public
health insurance. However after the Rose Revolution in
2003 the changing political ideology led to the abolish-
ment of the public health insurance and VHI has become
the principal mechanism for pre-payment of health ser-
vices. Those not belonging to the defined groups of the
poor and pensioners benefiting from subsidized health in-
surance had to revert to VHI as primary (principal) cover-
age. Accompanied by relatively weak regulation, this is
reflected in the rise in VHI% from 2003 onwards [61].
In summary, VHI has largely a supplementary/comple-
mentary role in most EURO countries studied here,
whereby higher income groups in particular demand VHI.
South-East Asian Region (SEARO)
VHI in its various roles has played a rather moderate
role so far in SEARO, which is reflected in its very low
average VHI% trend lines (see Fig. 3) compared to other
regions. From 2011 it had the lowest VHI% average of
all the regions.
Out of 10 SEARO LMIC only five (Thailand, Maldives,
India, Indonesia and Sri Lanka) reported a VHI% > 1 %
in any year between 2008 and 2012 (see Fig. 10). With
the exception of Indonesia all countries have reported
arise in VHI% since 1995. In two countries (Sri Lanka
and Maldives), GGHE% decreases, while both OOP%
and VHI% increase which is a less desirable scenario. In
the remaining countries GGHE% increases and OOP%
goes down, while VHI% goes up (in Thailand and India)
or down (in Indonesia) (see Additional file 2).
Despite the moderate role of VHI% in SEARO, VHI ex-
penditure per capita is growing gradually. One significant
Fig. 10 SEARO Individual country trends of PHI%, 1995–2012
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explanatory factor in SEARO is economic growth of parts
of the region and the growing middle class with expanding
health care demands. For example, for Thailand, Drechsler
and Jütting reported that the growing middle classes are
assumed to be the most likely consumers of supplemen-
tary VHI [9]. By contrast, in Indonesia limited VHI growth
of approximately 20 ‘bapels’, which are HMO type organi-
sations accessed through a voluntary insurance scheme,
has been attributed to the belief that they are of poor qual-
ity and provide limited choice [62]. Additionally, coverage
for formal sector workers was expanded and the govern-
ment provided funding to subsidize coverage for poor
population groups, called Jamkesmas [63], which led to an
expansion of GGHE.
While India has one of the largest private provider
health sectors in the world, VHI% is still relatively small
(0.8 % in 1995–3.1 % in 2012), against a notably high
share of OOP expenditure. The growth of India's VHI
market is due to growing demands of an emergent
wealthier middle class for supplementary/complemen-
tary VHI and the expansion of numerous CBHI schemes
for the poorer populations [64]. During the 2000s, un-
clear guidance from India's regulatory bodies for insurers
has been attributed as a factor for restricted growth [65].
In summary, economic growth and the growing
middle-class with expanding health care demands can be
seen as a common reason for a rising VHI% trend in
particular in some countries in the SEARO region.
Western Pacific Region (WPRO)
As for SEARO countries, VHI has also played a rather
moderate role so far in WPRO countries, which is
reflected in the relatively low average VHI% trend lines
for the region (see Fig. 3).
There are 21 LMIC countries in WPRO (out of the 37
countries and areas that make up the region), with only
one country not reporting on VHI expenditure. Nine of
these reported a VHI% > 1 % in any one year between
2008 and 2012, five of which were pacific islands. Mean-
while ten countries reported that none of their THE was
spent on VHI, the highest number across all the regions.
Of the countries included in the country trend analysis,
a general upwards trend can be seen in half of the coun-
tries (see Figs. 11 and 12). The data has been split into
two graphs; non-pacific island states (Fig. 11) and pacific
island states (Fig. 12).
GGHE% increases in five out of nine countries in
WPRO, but there is no observable pattern with respect
to changes in OOP% and VHI%. The remaining four
countries where GGHE% decreases, both OOP% and
VHI% increase (see Additional file 2); this is the less de-
sirable scenario on the path of moving equitably towards
UHC.
As for SEARO, one significant explanatory factor in
WPRO for changes in VHI seems again to be economic
growth of parts of the region and sectors of the population
with expanding health care demands. In Malaysia, VHI
mostly targets the more affluent parts of the population
[66, 67], which together with increasing wealth in the
upper middle classes has led to a gradual rise in VHI%.
Similarly in the Philippines, even though its government
has made efforts to expand the public health insurance
package (PhilHealth), VHI% increased from 3.7 to 7.3 %
between 1995 and 2012. This could be explained by an in-
crease in additional services offered by VHI that are
Fig. 11 WPRO Individual country trends of VHI%, 1995–2012, non-pacific island states
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particularly attractive for the increasing middle class, as
the PhilHealth package is limited in benefits [68].
For Vietnam, no VHI data is reported in the GHED.
However, evidence and previous analysis of VHI trends in
the country [11] reveals that despite substantial UHC ex-
tension efforts and government subsidies for the public
health insurance system, duplicative VHI plays an import-
ant role [69]. A major problem is that VHI regulation is
not coordinated with the ministry of health’s efforts to ex-
pand coverage via the Vietnam Social Security scheme. In
China, the VHI sector was opened up to foreign compan-
ies in 1992 [70]. The modest increase in VHI% is largely
the result of the expansion of the upper middle class that
buys complementary/supplementary VHI coverage on top
of the existing public health insurance programs [71].
Up to now, overall, VHI has played a rather marginal
role in South East Asia and Western Pacific Regions in
contrast to the economic potential of parts of the regions.
Global VHI% trends in LMIC
While data is missing for around one fifth of all LMIC over
the period between 1995 and 2012, a slight upward trend
of VHI% can be seen on average. VHI% increased in 68
LMIC (including the recent HICs). Yet the rise in regional
averages of VHI% has been less than one percentage point
(and 2 percentage points in EURO) over this whole period,
and thus rather modest. Nonetheless, many individual
AMRO and AFRO countries show larger increases. In a
few countries the increase in VHI% between 1995 and 2012
was above 5 percentage points, namely in Botswana,
Georgia, Suriname and Senegal. On the other hand, in 30
LMIC, VHI% decreased. While more recent VHI market
developments largely relate to the expansion of supplemen-
tary/complementary coverage in many countries, in some
countries with historic and markedly higher VHI% this has
been driven by primary VHI. Existence and changes in du-
plicate coverage appear to have been less pertinent, al-
though its relevance could only be established on the basis
of a detailed country by country analysis of the actual VHI
policy and national SHI laws.
It is also interesting to note the shifts between VHI%,
OOP% and GGHE% between 1995 and 2012 to reveal how
countries progress towards UHC: Out of the 74 countries
included in the detailed individual country trend analyses
(with VHI% > 1 % in any one year between 2008 and 2012),
29 countries had a rise in VHI% and GGHE%, while
OOP% declined, but eight out of these still had OOP% >
40 %. Yet, seventeen countries had a rise in VHI% plus a
rise in OOP% and a fall in GGHE%, which is an undesir-
able trend on the path towards UHC. Moreover, eight out
of these 17 countries still had OOP% >40 % of THE (see
Additional file 2).
Discussion
From 193 countries worldwide in 2012, 163 had avail-
able data. Out of 138 LMIC, VHI expenditure was insig-
nificant in 49 LMIC, i.e. with VHI% below 1 % or
reported as 0 %. VHI% ranged from 1 % to 5 % in 56
countries of all income levels, with 39 of these being
LMIC and 3 having recently become HIC. VHI% was
above 5 % in 46 countries worldwide, 23 of these being
LMIC and 3 being new HIC. In 2001, in comparison,
VHI% was above 5 % in 39 countries worldwide, with 25
of these being LMIC then [8]. The absolute number of
countries of all incomes with VHI% >5 % has increased
between 1995 and 2012, from 36 to 46. The overall aver-
age global trend of VHI% in LMIC between 1995 and
2012 is slightly upwards. This increase has been noted
Fig. 12 WPRO Individual country trends of VHI%, 1995–2012, pacific island states
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by studies of NHA data prior to 2002 [10] and has also
taken place over the last 10 years as observed in this
study. Moreover, we need to keep in mind that underre-
porting and general difficulties in obtaining data may
imply that VHI expenditure is actually higher than sug-
gested by the data presented here.
Analysis of changes in OOP% between 1995 and 2012
indicates that increases in VHI% cannot be consistently
linked with OOP% falling or being redirected into volun-
tary prepayment. This suggests that generally VHI is not
effective in covering gaps in publicly financed coverage.
There were also several countries where despite a rise in
VHI% there has been a rise in OOP% coupled with a fall
in GGHE%.
Diverse reasons for the VHI expenditure trends were
identified in the previous section, from these three over-
arching themes emerge: 1) external influences; 2) gov-
ernment policies on the role of VHI and its regulation;
and 3) willingness and affordability of various population
segments to pay to enrol in VHI schemes. These themes
are interrelated, and can increase or decrease VHI ex-
penditure depending on the country context.
External influences
External influences were one driving factor for increases
in VHI expenditure. Several Latin American countries
underwent structural adjustment programmes in the
1980s. International trade agreements to attract foreign
investment, like in Georgia, and market oriented
liberalization efforts have tended to encourage the
growth of the private sector and the reduction of invest-
ment in the public sector. This attracted interest from
overseas VHI companies and resulted in AMRO having
the greatest proportion of LMICs with a VHI% >10 %.
Likewise, in post-apartheid South Africa such policies
led to the further growth of the private sector and
overseas investment.
Another cause for VHI changes are development part-
ners and international donors that influence health policy
or provide external funding. They contributed significantly
to the promotion of CBHI in terms of numbers of
schemes, primarily in sub-Saharan Africa. However, the
absolute VHI expenditure increases due to CBHI have
been marginal, largely due to relatively low enrolment
rates [22].
Government policy on the role of VHI and its regulation
In most LMIC, VHI has so far played a limited role,
whereas in some countries it has played a more import-
ant role. Yet, the role of VHI is often not adequately
reflected in health sector policies and is largely absent in
health financing policies or health financing strategies,
as was revealed when screening such documents, which
are available on the IHP+ platform [18]. In some
strategies VHI is mentioned as complementing and sup-
plementing health financing, but in what form, and what
regulation will be required is often not specified.
One challenge is that VHI often does not fall under the
policy and regulation of the ministry of health. When reg-
ulated by the Ministry of Finance or another ministry,
their policy objective is often private sector growth (in-
cluding VHI). If not aligned and regulated, this could
contradict UHC and financial protection objectives.
The country analyses reveal that regulation has been
weak overall, and this has had various effects. On the one
hand, a general lack of regulation enhanced the expansion
of primary as well as supplementary and complementary
VHI in several countries. This has been documented for
South Africa during apartheid and many parts of Latin
America, where VHI was described to have developed in a
“legal vacuum” coupled with laissez faire market oriented
policies. VHI has also been noted to grow in post-conflict
countries, such as Lebanon, potentially due to limited cap-
acity of public institutions to regulate private industries.
On the other hand, the lack of a regulatory framework
such as in Mexico or India may have inhibited the antici-
pated development of primary (substitutive) or supple-
mentary/complementary VHI. The absence of a secure
legal framework for VHI companies to grow and profit
can be a significant disincentive to investment.
This also seems to explain expenditure trends in the
two large emerging economies China and India. These
can be considered together as there has been speculation
that India's and China's VHI market would expand rap-
idly, with their anticipated economic growth [9]. These
countries have had the greatest % increases in VHI expend-
iture per capita in their respective region, but it is still
within the average range. However trend analysis of overall
VHI% growth for India since 1995 is still modest, and
VHI% actually decreased in China since 2008. This perhaps
less than anticipated VHI% growth has been attributed to
inadequate clarity regarding government and health regula-
tors’ policies on the role of VHI [65]. It should be empha-
sized however that aggregate figures for large countries
with marked social gradients, such as India and China,
may mask substantial increases in VHI expenditure within
certain segments of the population. It should also be noted
that VHI% are affected by changes in OOP and GGHE,
which also contribute to THE.
Although less frequent, explicit government policy to ex-
pand VHI has played a role in some countries. For example,
the promotion of CBHI as a key pillar for UHC expansion
foremost in West African countries, the introduction of a
regulatory framework and a federation of CBHIs to support
their growth in Senegal, the promotion of principal VHI
coverage in Georgia, or legislation to allow people to opt
out of public health insurance in favour of substitutive VHI
in Chile. In fact, although CBHI expenditure is rather
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marginal in Africa and Asia, its existence and promotion
through donors and development partners has made it in
some countries turn into a strong political actor and poten-
tially an overvalued health financing mechanism. A crucial
yet unrealistic role of CBHI contributing towards UHC has
been ascribed by envisaging to cover the informal sector
population which is often more than 80 % of the popula-
tion. Assigning such a role to CBHI may have also poten-
tially detracted governments in the past from expanding
publicly financed coverage and from increasing GGHE.
In contrast explicit government regulation intended to
limit VHI activity and increase investment in GGHE was
seen in post-apartheid South Africa and post-military rule
Chile, where social movements to diminish inequities
precipitated a shift in government policies. However
the success of such policies was limited by existing VHI
industry interests operating in a primary VHI market.
This is an important lesson for countries on the path to
UHC, suggesting that although VHI may be considered
to help increase pre-payment mechanisms and reduce
financial risk in the first instance if vested interests be-
come significant this may hinder future efforts to ex-
pand GGHE.
Willingness and affordability to enrol in VHI schemes
A common issue across all regions is the emergence of a
middle class with disposable income and the desire to
access better quality health services. This is often the
case when the services provided by the public system do
not meet expectations, and in some countries has been
catalysed by the labour unions of private companies ne-
gotiating VHI for their workers. The growth in purchas-
ing power by a segment of the population is seen in
emerging economies such as China, India and Thailand,
and was or continues to be a cause of growth in VHI in
its various roles in a diverse range of countries, such as
several upper-middle income countries in Latin Amer-
ica, EURO countries as well as Jordan and Botswana. Of
note existing inequality, as expressed by a high Gini-
coefficient, was found to be correlated with a higher
VHI% in previous studies [11].
On the other hand, various countries have experienced
the consequences of excessive fragmentation and limited
pooling of VHI, including CBHI schemes, which led to un-
affordable rising premiums and/or unsustainable schemes,
such as in Turkey, South Africa, Chile and Mexico. In
some cases this was precipitated by economic crises.
Limitations
Important limitations around the quality of VHI data
have been discussed in the methodology section. Unex-
plained sharp rises and falls of VHI expenditure which
were seen in a few countries point to possible variations
in the quality of data reporting. Country health financing
system reviews revealed that VHI plays an important role
in some countries, even when no VHI expenditure is re-
corded in the GHED or VHI is recorded as zero. This sug-
gests that there may be considerable under-reporting from
some countries, which confirms Drechsler and Jütting’s
(2010) assessment [11]. For example, detailed health finan-
cing system reviews of Lesotho revealed that there is an
important VHI market [72, 73] despite 0 % being recorded
in GHED, as is the case for Nigeria [74, 75] and Vietnam
[69]. Similarly, in Cameroon, there is no VHI expenditure
reported despite a growing number of CBHI schemes in
place covering about 2 % of the population [76]. It is also
likely that VHI continues to play a role in Zimbabwe al-
though unrecorded.
Underreporting is also due to the fact that GHED re-
cords VHI expenditure, rather than VHI premiums col-
lected, i.e. revenues. In many countries, there are large
profit margins in the VHI market, and thus household
spending on VHI may be considerably above the re-
ported VHI expenditure of financing agents [77].
The literature analysis also had its limitations. It iden-
tified sometimes patchy and at times contradictory
causes to explain potential rises and falls in VHI% and
VHI expenditure in individual countries. However, clear
themes did emerge regarding potentially causal factors
for changes in VHI. These are applicable taking into ac-
count different country contexts.
Conclusion
Over the years several countries have paid insufficient
attention to the role of VHI. Much of the initial expan-
sion of VHI in many countries was a result of limited in-
vestment in the public sector as well as limited
regulation and thereafter its maintenance due to vested
interests, rather than a coordinated effort for it to
play an ancillary role in achieving UHC. In some
countries, VHI may have hindered moving equitably
towards UHC. Current health financing strategies
still put insufficient attention on specifying the role
of VHI on the path to UHC. A systematic review of
available health sector strategies would be useful to
provide more evidence on existing gaps. It is of high
importance that health financing strategies are clear
about the role they give to VHI in their path to-
wards UHC if previous oversights are not to be
repeated.
Future research could explore in more depth possible
associations between the rate of change in VHI expend-
iture and OOP, GGHE, THE or GDP as relative percent-
age changes or as per capita expenditure. Likewise more
work is needed to disaggregate data to understand how
these changes play out across different segments of the
population. Furthermore, attention needs to be placed
on improving data collection of VHI expenditure and its
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different roles at country level in order to better monitor
country and global trends.
An increasing number of LMICs are committed to accel-
erating progress towards UHC and actively engage in
reforming their health financing system. The focus needs to
be on increasing GGHE in order to more equitably pro-
gress towards UHC. Likewise, there is a need to align policy
objectives around private sector promotion (including VHI
promotion) by the Ministry of Finance or Ministry of In-
dustry with those of the Ministry of Health. It is clear that
better-off population groups will often demand access to
higher quality services from the private sector if the public
sector does not provide these.
Regulation is also important in countries with still rela-
tively slow growth in VHI expenditure, as this might
change with an expanding middle class and economic
growth. The point is thus to foster and regulate VHI in
such a way that it contributes to equitable progress to-
wards UHC. This is more likely to be so with VHI in its
complementary or supplementary role, in comparison
with primary and in particular substitutive VHI, with
an opt-out mechanism from public health insurance,
as well as duplicative coverage which can easily result
in fragmentation and segmentation, weakening risk
sharing, and reduced solidarity. In conclusion, there is
a strong need to wisely manage VHI in order to con-
tribute to a country’s endeavour to progress equitably
towards UHC.
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